Navigation Links
JDRF announces 2008 Scholar Award recipients
Date:8/1/2008

August 1, 2008, New York, NY - JDRF said today that it has recognized the work of two top diabetes researchers who are focused on accelerating the pace of science in understanding the autoimmune attack that causes type 1 diabetes, and on preventing or reversing the severe complications of this chronic and life-threatening disease.

The recipients of the third annual Scholar Award are Dr. Jeffrey A. Bluestone, Director of the Diabetes Center at the University of California in San Francisco and Dr. Mark E. Cooper, Director of the Baker IDI Heart and Diabetes Institute in Melbourne, Australia. The most prestigious distinction offered by JDRF, the Scholar Award provides recipients with $250,000 annually for up to five years for their specialized research.

The Scholar Award is granted to individual scientists with a track record of conducting pioneering, creative research and a commitment to conducting transformative research to finding a cure for diabetes and its complications.

"We are thrilled to name Dr. Bluestone and Dr. Cooper as recipients of JDRF's Scholar Award. They both exhibit a unique creative vision and approach to research that will accelerate the JDRF mission," said Dr. Richard Insel, Executive Vice President of Research for JDRF. "We depend on the creativity and excellence of our scientists to continue to accelerate the pace of research leading to a cure."

Dr. Bluestone, who has a long-term commitment to the field of autoimmunity and immune intolerance, received the award for his project, "Role of MicroRNAs in T cell function in Type 1 diabetes." The Scholar Award will allow Dr. Bluestone to explore the function of MicroRNA in regulatory T cells, which are critical for the prevention and control of autoimmune diabetes. MicroRNAs are small RNA molecules that can change gene expression by controlling whether certain proteins can be produced or not.

JDRF funds research to study the genetic and environme
'/>"/>

Contact: Jillian Lubarsky
jlubarsky@jdrf.org
212-479-7626
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
2. LaserCard Corporation Announces Expansion of Middle East Project
3. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
4. Balzan Foundation announces 2007 winners
5. The American Society of Plant Biologists announces 2007 awards
6. ASPB announces Summer Undergraduate Research Fellowship 2007 recipients
7. NIST announces 56 new awards for innovative technology research and development
8. Titanium Group Announces Contract With Haitong Securities
9. Measurement Specialties, Inc. Announces Impact of German Business Tax Reform 2008 Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
10. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change
11. HGS announces positive Phase 2 LymphoStat-B at ACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... may be just what the doctor orders for individuals suffering ... production or altered tear film composition. According to a study ... temperature less than 30 degrees Celsius on the eye and ... of the disorder. The study, (Meibomian Lipid Films and ...
... from the Swedish medical university Karolinska Institutet has deepened ... most fundamental processes, works. In a long term perspective ... The study is presented in the prestigious scientific journal ... yeast cells, researchers at Karolinska Institutet have discovered that ...
... Thursday, May 26, the University of Delaware will ... honor of Richard F. Heck, Willis F. Harrington ... of the 2010 Nobel Prize in Chemistry. Register ... Akira Suzuki of Japan,s Hokkaido University, and Ei-Ichi ...
Cached Biology News:Drop in temperature may explain the increase in dry eye suffering 2Research into chromosome replication reveals details of heredity dynamics 2Symposium honoring UD Nobel Laureate Richard Heck set for May 26 2
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)... ALTO, Calif. , Jan. 22. 2015  Varian Medical Systems ... and software, has been honored for its commitment to sustainability ... sustainable companies. Varian is the highest ranked healthcare equipment company ... announced today during the World Economic Forum at ...
(Date:12/25/2014)... The report “Service Quality Management and ... Provider Type - Global Advancements, Worldwide Forecasts & Analysis ... analysis and forecasting of revenues. , Browse 152 ... and in-depth TOC on “Service Quality Management (SQM) and ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Varian Honored Among World's 100 Most Sustainable Corporations 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4
... Mass., May 2, 2011 Richard Resnick, GenomeQuest,s ... on Tuesday, May 3, 2011, at the Biomarker ... Next Generation/Whole-Genome Sequencing on Companion Diagnostics" for pharmaceutical ... generation sequencing and data management technologies. ...
... 2011 Dyadic International, Inc. ("Dyadic") (OTC Pink: ... discovery, development, manufacture and sale of enzyme and ... enzyme industries, announced today that its research and ... entered into a research agreement with Sanofi Pasteur, ...
... 2, 2011 Saladax Biomedical, Inc., a privately held ... the promise of personalized medicine for new and existing ... team to expand its European presence. Reporting ... members of Saladax,s European commercialization team include: ...
Cached Biology Technology:GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics 2Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio 2Saladax Biomedical, Inc. Announces European Commercialization Team 2Saladax Biomedical, Inc. Announces European Commercialization Team 3
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Goat polyclonal to HA1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: TLGSCRERQPEFV from the C terminus of human HA1. Entrez GeneID: 23526 Swiss Protein ID: O78181...
Mouse monoclonal [X223] to Lamin B1 + B2 - Nuclear Envelope Marker ( Abpromise for all tested applications). entrezGeneID: 4001 SwissProtID: P20700...
Biology Products: